Literature DB >> 6604502

Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy.

F Furukawa, K Sekita, Y Hamashima, M Ozaki, S Imamura.   

Abstract

In 79 patients with leprosy a significant increase of anti-extractable nuclear antigen (ENA) antibodies and circulating immune complexes (CIC) was found. No correlation between CIC and anti-ENA antibodies was demonstrable. Since such a correlation is known from antinuclear antibodies and CIC in patients with systemic lupus erythematosus, it appears likely that anti-ENA antibodies do not play a causative role in CIC-mediated pathogenesis of leprosy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604502     DOI: 10.1007/bf00510043

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Fractionation of nucleic acids with the methylated albumin column.

Authors:  N SUEOKA; T Y CHENG
Journal:  J Mol Biol       Date:  1962-03       Impact factor: 5.469

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

5.  Estimation of the double-helical content in various single-stranded nucleic acids by treatment with a single strand-specific nuclease.

Authors:  K Shishido; T Ando
Journal:  Biochim Biophys Acta       Date:  1972-12-22

6.  Autoantibodies in leprosy.

Authors:  D J Wright
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

7.  Autoantibodies in leprosy.

Authors:  C Masala; M A Amendolea; M Nuti; R Riccarducci; C G Tarabini; C G Tarabini
Journal:  Int J Lepr Other Mycobact Dis       Date:  1979-06

8.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

9.  Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy.

Authors:  F Furukawa; M Ozaki; S Imamura; H Yoshida; A Pinrat; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT.

Authors:  D E Stewart-Tull; T Shimono; S Kotani; M Kato; Y Ogawa; Y Yamamura; T Koga; C M Pearson
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

View more
  5 in total

1.  Evaluation of anti-cardiolipin antibody and its cross-reactivity in sera of patients with lepromatous leprosy.

Authors:  F Furukawa; M Kashihara; S Imamura; G Ohshio; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay.

Authors:  F Furukawa; K Sekita; E Muso; S Imamura; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Dermatopathological studies on skin lesions of MRL mice.

Authors:  F Furukawa; H Tanaka; K Sekita; T Nakamura; Y Horiguchi; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

4.  Anti-hapten antibodies and autoantibodies in Japanese patients with lepromatous leprosy.

Authors:  F Furukawa; G Ohshio; M Ozaki; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

Review 5.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.